Global Motility Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Global Motility Systems Market Segmentation, By Product (Motility Testing Systems, Motility Therapy Systems, and Monitoring & Diagnostic Devices), Technology (High-resolution manometry (HRM), Impedance monitoring systems, Microfluidics-based systems, Real-time imaging & analysis systems, and Wireless capsule-based technologies), Application (Gastroesophageal disorders, Intestinal motility disorders, Colonic transit disorders, Esophageal motility disorders, Post-surgical gastrointestinal dysfunction, and Others), End User (Hospitals, Specialty clinics / gastroenterology centers, Diagnostic laboratories, Research institutes, Home care settings, and Others) – Industry Trends and Forecast to 2033

Motility Systems Market Size

• The global Motility Systems market size was valued at USD 650 Million in 2025and is expected to reach USD 1,100 Million by 2033, at a CAGR of 6.7% during the forecast period
• The market growth is primarily driven by the rising prevalence of gastrointestinal (GI) disorders, increasing adoption of advanced diagnostic technologies for early and accurate motility assessment, and growing awareness of functional digestive diseases across both developed and emerging economies
• In addition, continuous advancements in high-resolution manometry, capsule-based diagnostics, and real-time imaging systems are significantly improving diagnostic precision and workflow efficiency in gastroenterology, thereby supporting steady market expansion

Motility Systems Market Analysis

• Motility systems, which are used to evaluate and monitor gastrointestinal tract function, play a critical role in diagnosing disorders related to esophageal, intestinal, and colonic motility by providing precise functional and pressure-based assessments
• The growing demand for these systems is primarily driven by the increasing incidence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), chronic constipation, and functional bowel disorders, along with improved diagnostic awareness and expanding healthcare infrastructure
• North America dominated the motility systems market with the largest revenue share of 41.5% in 2025, supported by advanced gastroenterology care, high adoption of high-resolution diagnostic technologies, and strong presence of specialized GI clinics and research institutes
• Asia-Pacific is expected to be the fastest growing region during the forecast period, registering a CAGR of 8.2%, owing to rising healthcare investments, increasing prevalence of digestive disorders, and improving access to specialized diagnostic services across emerging economies
• Motility testing systems accounted for the largest market share in 2025, driven by their widespread use in clinical diagnosis of esophageal and intestinal motility disorders across hospitals and specialty centers

Report Scope and Motility Systems Market Segmentation

Motility Systems Market Trends

“Rising Adoption of High-Resolution and Capsule-Based Diagnostic Technologies in Gastrointestinal Motility Assessment”

• A significant and accelerating trend in the global motility systems market is the shift toward high-resolution, minimally invasive, and capsule-based diagnostic technologies that enhance patient comfort while improving diagnostic accuracy
• For instance, wireless capsule endoscopy and advanced HRM systems are increasingly being used to provide real-time, detailed functional mapping of gastrointestinal motility disorders
• Integration of digital analytics and AI-based interpretation tools is enabling more precise identification of motility abnormalities, reducing diagnostic variability and improving clinical decision-making
• Growing adoption of real-time imaging and impedance-based monitoring systems is enhancing the ability to assess complex motility disorders in both upper and lower GI tracts
• This trend toward more patient-friendly, data-driven, and high-precision diagnostic platforms is transforming gastrointestinal diagnostics and improving long-term disease management strategies

Motility Systems Market Dynamics

Driver

“Rising Prevalence of Gastrointestinal Disorders and Advancements in Diagnostic Technologies”

• The increasing global burden of gastrointestinal motility disorders, including GERD, chronic constipation, and functional bowel diseases, is a key factor driving demand for advanced motility systems
• For instance, healthcare providers are increasingly adopting high-resolution manometry and capsule-based systems to improve diagnostic accuracy and patient outcomes in complex GI cases
• Growing awareness of early diagnosis and personalized treatment approaches is encouraging wider use of motility testing systems in clinical practice
• In addition, expanding gastroenterology infrastructure in emerging markets is improving access to advanced diagnostic tools, further supporting market growth
• Technological advancements enabling faster, more accurate, and less invasive diagnostic procedures are significantly enhancing adoption across hospitals and specialty clinics

Restraint/Challenge

“High Equipment Costs and Limited Specialist Availability”

• The high cost of advanced motility diagnostic systems, particularly high-resolution and capsule-based technologies, poses a significant barrier to widespread adoption, especially in low- and middle-income regions
• Limited availability of trained gastroenterology specialists capable of interpreting complex motility data further restricts optimal utilization of these systems
• Variability in reimbursement policies for advanced diagnostic procedures can limit patient access and slow adoption rates in certain healthcare systems
• In addition, the complexity of device operation and data interpretation can create workflow challenges in smaller healthcare facilities
• Addressing these challenges through cost optimization, improved training programs, and simplified diagnostic interfaces will be critical for sustained market expansion

Motility Systems Market Scope

The market is segmented on the basis of product, technology, application, and end user.

• By Product

On the basis of product, the global motility systems market is segmented into motility testing systems, motility therapy systems, and monitoring & diagnostic devices. The motility testing systems segment dominated the market with the largest revenue share of 48.6% in 2025, driven by their extensive use in the diagnosis of esophageal, intestinal, and colonic motility disorders across clinical and hospital settings. These systems, including high-resolution manometry (HRM) platforms, are widely preferred due to their high diagnostic accuracy, ability to evaluate pressure dynamics in real time, and strong clinical validation in gastroenterology practice. Increasing prevalence of gastrointestinal (GI) disorders such as GERD, chronic constipation, and functional bowel disorders further strengthens demand for motility testing systems. Continuous technological improvements and growing adoption in specialty gastroenterology centers also support segment dominance.

The monitoring & diagnostic devices segment is expected to witness the fastest growth during the forecast period, fueled by rising demand for advanced, minimally invasive, and real-time GI monitoring solutions. The increasing adoption of capsule-based diagnostic systems and wireless monitoring technologies is expanding clinical capabilities for assessing complex motility disorders. Growing preference for outpatient diagnostics and patient-friendly procedures is accelerating uptake in both developed and emerging healthcare markets. In addition, integration of AI-enabled analysis and digital reporting tools is enhancing diagnostic efficiency and driving segment expansion globally.

• By Technology

On the basis of technology, the market is segmented into high-resolution manometry (HRM), impedance monitoring systems, microfluidics-based systems, real-time imaging & analysis systems, and wireless capsule-based technologies. The high-resolution manometry (HRM) segment accounted for the largest market share in 2025, driven by its status as the gold standard for evaluating esophageal motility disorders. HRM systems provide detailed pressure topography and highly accurate functional assessment, making them widely adopted in hospitals and gastroenterology clinics. Increasing diagnosis of esophageal motility disorders and strong physician preference for standardized testing protocols further support segment leadership.

The wireless capsule-based technologies segment is anticipated to register the fastest growth during the forecast period, supported by rising demand for non-invasive and patient-friendly diagnostic solutions. These technologies enable extended monitoring of gastrointestinal transit without discomfort associated with catheter-based systems. Advancements in capsule miniaturization, imaging resolution, and real-time data transmission are significantly improving clinical adoption. Growing preference for outpatient diagnostics and home-based monitoring is further accelerating segment growth globally.

• By Application

On the basis of application, the market is segmented into gastroesophageal disorders, intestinal motility disorders, colonic transit disorders, esophageal motility disorders, post-surgical gastrointestinal dysfunction, and others. The esophageal motility disorders segment dominated the market with the largest revenue share of ~32.5% in 2025, driven by the high prevalence of conditions such as achalasia, diffuse esophageal spasm, and GERD-related motility abnormalities. Increasing use of HRM systems for accurate diagnosis and classification of esophageal disorders significantly contributes to segment dominance. Rising awareness among clinicians regarding early detection of esophageal dysfunction further supports growth.

The intestinal motility disorders segment is expected to witness the fastest growth during the forecast period, fueled by increasing incidence of irritable bowel syndrome (IBS), chronic constipation, and functional gastrointestinal disorders. Growing adoption of advanced diagnostic tools for evaluating complex bowel motility patterns is driving segment expansion. In addition, rising patient awareness and improved access to gastroenterology care in emerging economies are accelerating diagnosis rates.

• By End User

On the basis of end user, the market is segmented into hospitals, specialty clinics / gastroenterology centers, diagnostic laboratories, research institutes, home care settings, and others. Hospitals dominated the market in 2025 with a revenue share of ~44.1%, supported by high patient inflow for gastrointestinal diagnostics, availability of advanced motility testing infrastructure, and strong integration of gastroenterology departments. Hospitals remain the primary setting for complex diagnostic procedures such as HRM and impedance studies, reinforcing segment leadership.

Specialty clinics / gastroenterology centers are expected to register the fastest growth during the forecast period, driven by increasing preference for specialized and outpatient GI diagnostic services. Rising establishment of dedicated GI centers and growing physician-led diagnostic practices are supporting segment expansion. In addition, improved accessibility to advanced motility systems in ambulatory care settings is enhancing patient convenience and boosting adoption globally.

Motility Systems Market Regional Analysis

• North America dominated the motility systems market with the largest revenue share of 41.5% in 2025, supported by advanced gastroenterology infrastructure, high adoption of high-resolution diagnostic technologies, and a strong presence of leading medical device manufacturers and specialized GI centers
• Patients and healthcare providers in the region place strong emphasis on early and accurate diagnosis of gastrointestinal motility disorders, leading to widespread adoption of motility testing systems across hospitals, specialty clinics, and research institutes
• This strong market position is further supported by high healthcare expenditure, well-established reimbursement frameworks, and rapid integration of advanced diagnostic platforms such as high-resolution manometry (HRM) and capsule-based technologies, making motility systems a standard component of modern GI diagnostics

U.S. Motility Systems Market Insight

The U.S. motility systems market captured the largest revenue share in North America in 2025, driven by a high prevalence of gastrointestinal disorders such as GERD, chronic constipation, and irritable bowel syndrome (IBS), along with strong access to advanced diagnostic infrastructure. Clinicians increasingly rely on HRM, impedance monitoring, and capsule-based systems for precise functional assessment of GI motility disorders. Growing adoption of minimally invasive diagnostic techniques, coupled with strong research activity in gastroenterology, continues to drive market expansion. In addition, favorable reimbursement policies and the presence of leading medical technology companies significantly support sustained market growth.

Europe Motility Systems Market Insight

The Europe motility systems market is projected to expand at a steady CAGR during the forecast period, primarily driven by rising prevalence of functional gastrointestinal disorders and strong clinical emphasis on early diagnosis and standardized testing protocols. Increasing adoption of advanced diagnostic technologies, including high-resolution manometry and real-time imaging systems, is supporting market growth across hospitals and specialty clinics. Aging populations and growing awareness of digestive health are further contributing to sustained demand. In addition, well-established healthcare systems and favorable reimbursement structures are enabling broader access to advanced motility diagnostic procedures.

U.K. Motility Systems Market Insight

The U.K. motility systems market is anticipated to grow at a notable CAGR during the forecast period, supported by increasing diagnosis rates of functional GI disorders and strong adoption of evidence-based clinical guidelines in gastroenterology. The National Health Service (NHS) plays a key role in expanding access to advanced motility testing, particularly for esophageal and colonic disorders. Rising awareness of chronic digestive conditions and expanding outpatient diagnostic services are further supporting market growth. In addition, increasing use of digital health platforms and referral-based gastroenterology care is improving patient access to specialized diagnostic procedures.

Germany Motility Systems Market Insight

The Germany motility systems market is expected to expand at a considerable CAGR during the forecast period, driven by strong focus on precision diagnostics and high adoption of advanced medical technologies. The country’s emphasis on early detection and structured clinical workflows supports widespread use of HRM and impedance-based diagnostic systems. Growing investment in gastroenterology research and clinical innovation is further strengthening market development. In addition, Germany’s preference for high-quality, regulated medical devices is encouraging adoption of technologically advanced motility diagnostic platforms.

Asia-Pacific Motility Systems Market Insight

The Asia-Pacific motility systems market is poised to grow at the fastest CAGR during 2026–2033, driven by rising prevalence of gastrointestinal disorders, rapid healthcare infrastructure expansion, and increasing awareness of digestive health across countries such as China, India, and Japan. Growing investments in diagnostic healthcare facilities and expanding access to specialist gastroenterology services are accelerating adoption of motility testing systems. In addition, increasing urbanization, dietary changes, and improved healthcare spending are contributing to higher diagnosis rates. The region’s expanding medical device manufacturing base is also improving affordability and availability of advanced diagnostic technologies.

Japan Motility Systems Market Insight

The Japan motility systems market is gaining momentum due to the country’s aging population and high incidence of chronic gastrointestinal conditions. Strong emphasis on early diagnosis and advanced clinical precision is driving adoption of HRM and capsule-based diagnostic technologies. Healthcare providers increasingly utilize minimally invasive systems to improve patient comfort and diagnostic accuracy. Integration of advanced motility systems into hospital and outpatient settings continues to support long-term market growth, particularly in elderly care management.

India Motility Systems Market Insight

The India motility systems market accounted for the largest revenue share in Asia-Pacific in 2025, attributed to rising prevalence of gastrointestinal disorders, rapid urbanization, and increasing healthcare awareness. Expanding access to gastroenterology services and growing availability of advanced diagnostic technologies are driving higher adoption rates across hospitals and specialty clinics. Cost-effective diagnostic solutions and improving healthcare infrastructure are further supporting market expansion. In addition, government initiatives aimed at strengthening diagnostic healthcare capabilities and strong domestic medical device manufacturing are key factors accelerating market growth in India.

Motility Systems Market Share

The Motility Systems industry is primarily led by well-established companies, including:

• Medtronic plc (Ireland)
• Laborie Medical Technologies (Canada)
• Diversatek Healthcare (U.S.)
• MMS Medical Measurement Systems (Netherlands)
• ALACER Biomed (Turkey)
• Synectics Medical (U.K.)
• Given Imaging (Medtronic) (Israel)
• Sandhill Scientific (Laborie) (U.S.)
• Standard Instruments GmbH (Germany)
• Cook Medical (U.S.)
• Sierra Scientific Instruments (U.S.)
• CapsoVision Inc. (U.S.)
• BioView (Israel)
• Royal Philips (Netherlands)
• Fujifilm Holdings Corporation (Japan)
• Olympus Corporation (Japan)
• Pentax Medical (HOYA Group) (Japan)

What are the Recent Developments in Global Motility Systems Market?

• In May 2025, AnX Robotica announced FDA 510(k) clearance for its next-generation MotiliCap™ and MotiliScan™ GI motility system, enabling non-invasive whole-gut transit assessment with enhanced accuracy and patient comfort. The system replaces legacy SmartPill technology and integrates advanced software-based motility visualization, strengthening capsule-based GI diagnostic capabilities in the motility systems market.
• In October 2025, Medtronic launched the Endoflip™ 300 impedance planimetry system in India, expanding its gastrointestinal motility diagnostics portfolio. The system enables real-time measurement of esophageal, pyloric, and anal sphincter function during endoscopic evaluation, improving diagnosis of esophageal motility disorders and strengthening Medtronic’s position in advanced GI functional diagnostics.
• In December 2025, Medtronic continued expansion of its minimally invasive and diagnostic ecosystem through broader integration of advanced surgical and digital healthcare platforms, reinforcing its leadership in precision diagnostics and connected operating room solutions, which indirectly supports adoption of advanced GI motility evaluation technologies.

SKU-75902